136 related articles for article (PubMed ID: 34957163)
21. Innovativeness of nurse leaders.
Clement-O'Brien K; Polit DF; Fitzpatrick JJ
J Nurs Manag; 2011 May; 19(4):431-8. PubMed ID: 21569140
[TBL] [Abstract][Full Text] [Related]
22. Quantitative Assessment of Premium Rates for Clinical Usefulness in New Drug Price Calculation in Japan.
Takayama A; Kobayashi E; Nakamura T; Narukawa M
Ther Innov Regul Sci; 2017 Sep; 51(5):582-588. PubMed ID: 30231680
[TBL] [Abstract][Full Text] [Related]
23. The relationship between demographic and occupational variables, transformational leadership perceptions and individual innovativeness in nurses.
Sarıköse S; Türkmen E
J Nurs Manag; 2020 Jul; 28(5):1126-1133. PubMed ID: 32497365
[TBL] [Abstract][Full Text] [Related]
24. How to anticipate the assessment of the public health benefit of new medicines?
Massol J; Puech A; Boissel JP;
Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
[TBL] [Abstract][Full Text] [Related]
25. An Exploratory Descriptive Study of Registered Nurse Innovation: Implications for Levels of Adoption.
Polster D; Villines D
Clin Nurse Spec; 2017; 31(1):E1-E9. PubMed ID: 27906736
[TBL] [Abstract][Full Text] [Related]
26. Information on new drugs at market entry: retrospective analysis of health technology assessment reports versus regulatory reports, journal publications, and registry reports.
Köhler M; Haag S; Biester K; Brockhaus AC; McGauran N; Grouven U; Kölsch H; Seay U; Hörn H; Moritz G; Staeck K; Wieseler B
BMJ; 2015 Feb; 350():h796. PubMed ID: 25722024
[TBL] [Abstract][Full Text] [Related]
27. Relationship between individualized care perception and innovativeness among final-year nursing students.
Demirel N; Turan N
Perspect Psychiatr Care; 2021 Apr; 57(2):891-899. PubMed ID: 33000475
[TBL] [Abstract][Full Text] [Related]
28. Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data.
Amato L; Fusco D; Acampora A; Bontempi K; Rosa AC; Colais P; Cruciani F; D'Ovidio M; Mataloni F; Minozzi S; Mitrova Z; Pinnarelli L; Saulle R; Soldati S; Sorge C; Vecchi S; Ventura M; Davoli M
Epidemiol Prev; 2017; 41(5-6 (Suppl 2)):1-128. PubMed ID: 29205995
[TBL] [Abstract][Full Text] [Related]
29. Innovate or game over? Examining effects of product innovativeness on video game success.
Handrich F; Heidenreich S; Kraemer T
Electron Mark; 2022; 32(2):987-1002. PubMed ID: 35602113
[TBL] [Abstract][Full Text] [Related]
30. Association between pacifier use and breast-feeding, sudden infant death syndrome, infection and dental malocclusion.
Callaghan A; Kendall G; Lock C; Mahony A; Payne J; Verrier L
JBI Libr Syst Rev; 2005; 3(6):1-33. PubMed ID: 27819973
[TBL] [Abstract][Full Text] [Related]
31. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
32. Exploring health information technology innovativeness and its antecedents in Canadian hospitals.
Paré G; Jaana M; Sicotte C
Methods Inf Med; 2010; 49(1):28-36. PubMed ID: 20011805
[TBL] [Abstract][Full Text] [Related]
33. Finding links between organisation's culture and innovation. The impact of organisational culture on university innovativeness.
Gorzelany J; Gorzelany-Dziadkowiec M; Luty L; Firlej K; Gaisch M; Dudziak O; Scott C
PLoS One; 2021; 16(10):e0257962. PubMed ID: 34624041
[TBL] [Abstract][Full Text] [Related]
34. How to Value Orphan Drugs? A Review of European Value Assessment Frameworks.
Blonda A; Denier Y; Huys I; Simoens S
Front Pharmacol; 2021; 12():631527. PubMed ID: 34054519
[No Abstract] [Full Text] [Related]
35. Defining "innovativeness" in drug development: a systematic review.
Kesselheim AS; Wang B; Avorn J
Clin Pharmacol Ther; 2013 Sep; 94(3):336-48. PubMed ID: 23722626
[TBL] [Abstract][Full Text] [Related]
36. [The origin of informed consent].
Mallardi V
Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
[TBL] [Abstract][Full Text] [Related]
37. Can we predict firms' innovativeness? The identification of innovation performers in an Italian region through a supervised learning approach.
Gandin I; Cozza C
PLoS One; 2019; 14(6):e0218175. PubMed ID: 31185045
[TBL] [Abstract][Full Text] [Related]
38. Registries supporting new drug applications.
Jonker CJ; van den Berg HM; Kwa MSG; Hoes AW; Mol PGM
Pharmacoepidemiol Drug Saf; 2017 Dec; 26(12):1451-1457. PubMed ID: 28983992
[TBL] [Abstract][Full Text] [Related]
39. How Safe and Innovative Are First-in-Class Drugs Approved by Health Canada: A Cohort Study.
Lexchin J
Healthc Policy; 2016 Nov; 12(2):65-75. PubMed ID: 28032825
[TBL] [Abstract][Full Text] [Related]
40. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
